ASX Announcements Archive 2010
16 Dec 2010
Securities Trading Policy
15 Dec 2010
Substantial Holding Notice for Antisense Therapeutics Limited
19 Nov 2010
Change of Directors Interest Notice
18 Nov 2010
Circadian Technologies Limited Sale of Unmarketable Parcels Complete
18 Nov 2010
Open Briefing - VEGF Inhibitor Technology Patents
11 Nov 2010
Results of Annual General Meeting 11 November 2010
10 Nov 2010
Major US and European Patents Granted to Circadian
14 Oct 2010
Open Briefing - CEO on FY11 LAM Diagnostic Partnership
11 Oct 2010
Notice of Annual General Meeting and Explanatory Memorandum
11 Oct 2010
2010 Annual Report
05 Oct 2010
Finance News Network Video Interview with CEO (CIR)
30 Sep 2010
Circadian partners with Cincinnati Childrens Hospital in U.S. to develop blood test diagnostic for...
17 Sep 2010
Circadian Technologies Limited to Offer Shareholder Sale Facility for Unmarketable Parcels
09 Sep 2010
Open Briefing - CEO on FY11 Outlook and Strategic Focus
06 Sep 2010
Circadian granted key strategic VEGF-D patent in USA for diagnostic applications
25 Aug 2010
Change of Directors Interest Notice
20 Aug 2010
Preliminary Final Report (Appendix 4E) Financial Year Ended 30 June 2010
18 Aug 2010
Notice of Change of Interests of Substantial Holder
18 Aug 2010
Notice of Change of Interests of Substantial Holder
16 Aug 2010
Details of the issue or offer of securities
16 Aug 2010
New issue announcement, application for quotation of additional securities and agreement
30 Jul 2010
Shares to be released from escrow
14 May 2010
Change of Directors Interest Notice
13 May 2010
Change of Directors Interest Notice
13 May 2010
Change of Directors Interest Notice
13 May 2010
Ms Susan Madden appointed Company Secretary of Circadian
11 May 2010
Change of Directors Interest Notice
04 May 2010
VGX-100 Inhibits Tumour Growth - Open Briefing with CEO & MD Robert Klupacs
30 Apr 2010
Change of Directors Interest Notice
15 Apr 2010
Ms Natalie Korchev to resign as CFO and Company Secretary
15 Apr 2010
VGX-100 significantly inhibits tumour growth in animal cancer models
06 Apr 2010
Circadian Newsletter - April 2010
26 Mar 2010
Change in substantial holding
24 Mar 2010
Current Corporate Presentation
17 Feb 2010
Half Year Results and Operational Achievements
05 Feb 2010
Change in substantial holder